Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial - PubMed (original) (raw)
Randomized Controlled Trial
. 2015 Jan 20;131(3):254-62.
doi: 10.1161/CIRCULATIONAHA.114.011732. Epub 2014 Oct 30.
Yanna Song 1, Jeffery Dusek 1, Gregory Plotnikoff 1, Marc S Sabatine 1, Susan Cheng 1, Andre Valcour 1, Heather Swales 1, Beth Taylor 1, Erin Carney 1, Derek Guanaga 1, Joseph R Young 1, Courtney Karol 1, Michael Torre 1, Atum Azzahir 1, Semerit M Strachan 1, Dillon C O'Neill 1, Myles Wolf 1, Frank Harrell 1, Christopher Newton-Cheh 1, Thomas J Wang 2
Affiliations
- PMID: 25359163
- DOI: 10.1161/CIRCULATIONAHA.114.011732
Randomized Controlled Trial
Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial
Pankaj Arora et al. Circulation. 2015.
Abstract
Background: A large body of epidemiological and experimental evidence suggests that vitamin D deficiency may promote hypertension. This raises the possibility that vitamin D supplementation could be a simple intervention to reduce blood pressure, but data from prospective, randomized trials are limited.
Methods and results: A double-blind, randomized, controlled trial was conducted at 4 sites in the United States. We enrolled 534 individuals 18 to 50 years of age with low vitamin D status (25-hydroxyvitamin D levels ≤25 ng/mL) and systolic blood pressure of 120 to 159 mm Hg. Participants were randomized to high-dose (4000 IU/d) versus low-dose (400 IU/d) oral vitamin D3 for 6 months. The primary end point was change in mean 24-hour systolic blood pressure. Secondary end points included change in ambulatory diastolic blood pressure and clinic systolic and diastolic blood pressures. The median age was 38 years, and 62% of participants were men. Forty-six percent of participants were white, and 48% were black. The median 25-hydroxyvitamin D level at baseline was 15.3 ng/mL. Four-hundred fifty-five participants (85%) had at least 1 follow-up blood pressure measurement; 383 participants (72%) completed the full 6-month study. At the end of the study, there was no significant difference in the primary end point (change in mean 24-hour systolic blood pressure, -0.8 versus -1.6 mm Hg in the high-dose and low-dose arms; P=0.71) or in any of the secondary end points. Furthermore, there was no evidence of association between change in 25-hydroxyvitamin D and change in 24-hour systolic blood pressure at 6 months (Spearman correlation coefficient, -0.05, P=0.34). Results were consistent across prespecified subgroups.
Conclusions: Vitamin D supplementation did not reduce blood pressure in individuals with prehypertension or stage I hypertension and vitamin D deficiency. Our findings suggest that the association between vitamin D status and elevated blood pressure noted in observational studies is not causal.
Clinical trial registration url: http://www.clinicaltrials.gov. Unique identifier: NCT01240512.
Keywords: blood pressure; dietary supplements; hypertension; vitamin D deficiency.
© 2014 American Heart Association, Inc.
Similar articles
- Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial.
Pilz S, Gaksch M, Kienreich K, Grübler M, Verheyen N, Fahrleitner-Pammer A, Treiber G, Drechsler C, Ó Hartaigh B, Obermayer-Pietsch B, Schwetz V, Aberer F, Mader J, Scharnagl H, Meinitzer A, Lerchbaum E, Dekker JM, Zittermann A, März W, Tomaschitz A. Pilz S, et al. Hypertension. 2015 Jun;65(6):1195-201. doi: 10.1161/HYPERTENSIONAHA.115.05319. Epub 2015 Mar 23. Hypertension. 2015. PMID: 25801871 Clinical Trial. - Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial.
Witham MD, Price RJ, Struthers AD, Donnan PT, Messow CM, Ford I, McMurdo ME. Witham MD, et al. JAMA Intern Med. 2013 Oct 14;173(18):1672-9. doi: 10.1001/jamainternmed.2013.9043. JAMA Intern Med. 2013. PMID: 23939263 Clinical Trial. - Effect of Monthly, High-Dose, Long-Term Vitamin D Supplementation on Central Blood Pressure Parameters: A Randomized Controlled Trial Substudy.
Sluyter JD, Camargo CA Jr, Stewart AW, Waayer D, Lawes CMM, Toop L, Khaw KT, Thom SAM, Hametner B, Wassertheurer S, Parker KH, Hughes AD, Scragg R. Sluyter JD, et al. J Am Heart Assoc. 2017 Oct 24;6(10):e006802. doi: 10.1161/JAHA.117.006802. J Am Heart Assoc. 2017. PMID: 29066444 Free PMC article. Clinical Trial. - Effect of vitamin D3 supplementation on blood pressure in adults: An updated meta-analysis.
Golzarand M, Shab-Bidar S, Koochakpoor G, Speakman J R, Djafarian K. Golzarand M, et al. Nutr Metab Cardiovasc Dis. 2016 Aug;26(8):663-73. doi: 10.1016/j.numecd.2016.04.011. Epub 2016 Apr 25. Nutr Metab Cardiovasc Dis. 2016. PMID: 27287826 Review. - Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition.
Barnard K, Colón-Emeric C. Barnard K, et al. Am J Geriatr Pharmacother. 2010 Feb;8(1):4-33. doi: 10.1016/j.amjopharm.2010.02.004. Am J Geriatr Pharmacother. 2010. PMID: 20226390 Review.
Cited by
- Vitamin D and its associations with blood pressure in the Chronic Kidney Disease in Children (CKiD) cohort.
Kumar J, Roem J, Furth SL, Warady BA, Atkinson MA, Flynn JT; CKiD Study Investigators. Kumar J, et al. Pediatr Nephrol. 2024 Nov;39(11):3279-3288. doi: 10.1007/s00467-024-06434-1. Epub 2024 Jul 6. Pediatr Nephrol. 2024. PMID: 38970659 - Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes.
Nardin M, Verdoia M, Nardin S, Cao D, Chiarito M, Kedhi E, Galasso G, Condorelli G, De Luca G. Nardin M, et al. Biomedicines. 2024 Mar 30;12(4):768. doi: 10.3390/biomedicines12040768. Biomedicines. 2024. PMID: 38672124 Free PMC article. Review. - VITAMIN D DEFICIENCY AS AN INDEPENDENT PREDICTOR OF CARDIOVASCULAR DISEASE.
Frentusca CF, Babes K, Galusca DI. Frentusca CF, et al. Acta Endocrinol (Buchar). 2023 Jul-Sep;19(3):319-325. doi: 10.4183/aeb.2023.319. Epub 2024 Feb 1. Acta Endocrinol (Buchar). 2023. PMID: 38356981 Free PMC article. - Vitamin D Deficiency and Its Association With Cardiovascular Diseases Among Patients Attending a Private Tertiary Sector Cardiovascular Heart Clinic in Nairobi.
Gachemba YM, Khan Z, Njau E, Wanyoike M. Gachemba YM, et al. Cureus. 2023 Aug 6;15(8):e43012. doi: 10.7759/cureus.43012. eCollection 2023 Aug. Cureus. 2023. PMID: 37680439 Free PMC article. - Latest Knowledge on the Role of Vitamin D in Hypertension.
Jensen NS, Wehland M, Wise PM, Grimm D. Jensen NS, et al. Int J Mol Sci. 2023 Feb 28;24(5):4679. doi: 10.3390/ijms24054679. Int J Mol Sci. 2023. PMID: 36902110 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical